Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 10, 2026Aug 15 1:35 AMJonathan SheenaDirector, Other
Sale
6,000$325.32$2.0M230,464(D)

View →

Aug 7, 2026Aug 8 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
2,000$320.90$641.8K2,000(I)

View →

Aug 7, 2026Aug 8 1:35 AMJonathan SheenaDirector, Other
Sale
9,150$315.66$2.9M236,464(D)

View →

Aug 7, 2026Aug 7 9:42 PMTINKERBELLE II TR U/A DTD 10/22/2021
Proposed Sale
2,000$320.90$641.8K

View →

Aug 7, 2026Aug 7 2:41 PMSheena Jonathan
Proposed Sale
18,000$330.62$6.0M

View →

Aug 4, 2026Aug 6 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
478$274.22$131.1K51,637(D)

View →

Aug 3, 2026Aug 6 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
317$267.99$85.0K52,115(D)

View →

Aug 3, 2026Aug 6 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
3,076$266.39$819.4K99,897(D)

View →

Aug 3, 2026Aug 6 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
295$267.99$79.1K183,774(D)

View →

Aug 3, 2026Aug 6 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,410$265.58$905.6K129,019(D)

View →

Aug 3, 2026Aug 6 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
334$267.99$89.5K170,073(D)

View →

Aug 3, 2026Aug 6 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
731$267.99$195.9K2,275,394(D)

View →

Aug 3, 2026Aug 6 1:35 AMJonathan SheenaDirector, Other
Sale
109$267.99$29.2K245,614(D)

View →

Aug 4, 2026Aug 4 8:36 PMMICHAEL BROPHY
Proposed Sale
478$270.36$129.2K

View →

Aug 3, 2026Aug 3 8:22 PMJONATHAN SHEENA
Proposed Sale
108$267.76$28.9K

View →

Aug 3, 2026Aug 3 8:22 PMMATTHEW RABINOWITZ
Proposed Sale
722$267.76$193.3K

View →

Aug 3, 2026Aug 3 8:22 PMDANIEL RABINOWITZ
Proposed Sale
330$267.76$88.4K

View →

Aug 3, 2026Aug 3 8:21 PMSOLOMON MOSHKEVICH
Proposed Sale
405$267.76$108.4K

View →

Aug 3, 2026Aug 3 8:21 PMJOHN FESKO
Proposed Sale
292$267.76$78.2K

View →

Aug 3, 2026Aug 3 8:21 PMSTEVEN CHAPMAN
Proposed Sale
1,167$267.76$312.5K

View →

Page 1 of 14

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →